Article
Top 5 Most-Viewed Video Interviews of 2022
Author(s):
This year’s top 5 most-viewed videos include topics on eosinophilic esophagitis (EoE), cancer screening awareness, and racial/ethnic and socioeconomic barriers to care.
The top 5 most-viewed videos in 2022 on AJMC.com covered topics on eosinophilic esophagitis (EoE) education and awareness, improvements in cancer screening, and identifying racial and ethnic disparities.
Here are the top 5 videos interviews in 2022.
5. Dr Debra Patt Addresses the Importance of Cancer Screening Awareness, Strong Health Care Infrastructure
Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, spoke on how oncology outreach efforts have been effective in getting patients to come back, and the challenges in health care that still need to be overcome. Understaffing and a nursing shortage since the COVID-19 pandemic has exacerbated these challenges, she said.
4. Dr Victoria Ly Outlines Potential Future Research on Vision Screening Follow-up Disparities
Victoria Ly, MD, MPH, conducted a literature review that showed parents perceived affordability as a barrier to follow-up eye care, and suggested increasing Children's Health Insurance Program’s (CHIP) enrollment to help lessen this burden. She also spoke about future research, which would report demographics and socioeconomic background to help guide key policy makers.
3. EoE Affects Many Aspects of a Child's Quality of Life, Advocate Says
Colette Romero is an advocate for EoE awareness. As a mother of a son with EoE, Romero spoke about the challenges of EoE that have affected her son’s quality of life. Those challenges include hospital visits, malnutrition, having a very limited diet, social issues, and more.
2. EoE Advocate Colette Romero on Need for More Physician Education About Eosinophilic Disorders
In this interview, Romero spoke about how primary care providers need more education on EoE, since they are often the first to see a child with EoE symptoms. Gastroenterologists need more education and awareness as well. EoE is still a relatively new disease, and there are more treatment options available.
1. Dr Debra Patt on Capturing the HER2-Low Population
In this interview, Patt spoke on findings of DESTINY-Breast04. What this study showed is that low-patient HER-2 populations may have a better survival benefit from being treated with trastuzumab deruxtecan in comparison to chemotherapy.
